August 15, 2017
NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 22 NOVEMBER 2017
Media
August 14, 2017
Invitation to second quarter and first half 2017 results presentation Thursday 24 August
August 11, 2017
Notice of Nexstim Plc’s Half-Yearly Report H1 2017
August 10, 2017
Strongbridge Biopharma plc to Present at the Canaccord Genuity 37th Annual Growth Conference
August 10, 2017
Nordic Nanovector to Present at Wedbush PacGrow Healthcare Conference
August 10, 2017
Altimmune Announces Second Quarter 2017 Financial Results and Provides Corporate Update
August 07, 2017
Strongbridge Biopharma plc Provides Updates on KEVEYIS® Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial Results
August 02, 2017
Aprea Therapeutics Announces First Patient Enrolled in Phase Ib/II Clinical Study of APR-246 for the Treatment of Platinum-Resistant High-Grade Serous Ovarian Cancer
August 02, 2017
Zubsolv® gains preferred position on CVS Caremark 2018 formulary
August 01, 2017
GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of LHON
